Advertisement
Research Article Free access | 10.1172/JCI115523
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Gregory, T. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Longmore, W. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Moxley, M. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Whitsett, J. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Reed, C. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Fowler, A. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Hudson, L. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Maunder, R. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Crim, C. in: JCI | PubMed | Google Scholar
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.
Find articles by Hyers, T. in: JCI | PubMed | Google Scholar
Published December 1, 1991 - More info
Acute Respiratory Distress Syndrome (ARDS) is characterized by lung injury and damage to the alveolar type II cells. This study sought to determine if endogenous surfactant is altered in ARDS. Bronchoalveolar lavage was performed in patients at-risk to develop ARDS (AR, n = 20), with ARDS (A, n = 66) and in normal subjects (N, n = 29). The crude surfactant pellet was analyzed for total phospholipids (PL), individual phospholipids, SP-A, SP-B, and minimum surface tension (STmin). PL was decreased in both AR and A (3.48 +/- 0.61 and 2.47 +/- 0.40 mumol/ml, respectively) compared to N (7.99 +/- 0.60 mumol/ml). Phosphatidylcholine was decreased in A (62.64 +/- 2.20% PL) compared to N (76.27 +/- 2.05% PL). Phosphatidylglycerol was 11.58 +/- 1.21% PL in N and was decreased to 6.48 +/- 1.43% PL in A. SP-A was 123.64 +/- 20.66 micrograms/ml in N and was decreased to 49.28 +/- 21.68 micrograms/ml in AR and to 29.88 +/- 8.49 micrograms/ml in A. SP-B was 1.28 +/- 0.33 micrograms/ml in N and was decreased to 0.57 +/- 0.24 micrograms/ml in A. STmin was increased in AR (15.1 +/- 2.53 dyn/cm) and A (29.04 +/- 2.05 dyn/cm) compared to N (7.44 +/- 1.61 dyn/cm). These data demonstrate that the chemical composition and functional activity of surfactant is altered in ARDS. Several of these alterations also occur in AR, suggesting that these abnormalities occur early in the disease process.